Norway· NO-ID_96F9F21B-A168-4C30-9105-5E5530332A1E
Synacthen
A tetracosactide product containing tetrakosaktid, registered in Norway by Alfasigma S.p.A. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tetracosactide is registered in 10 of 19 countries.
Countries holding a registration under ATC H01AA02 (tetracosactide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Tetracosactide · ATC H01AA02
10 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Tetrakosaktid
- Manufacturer
- Alfasigma S.p.A
- Country
- Norway (NO)
- ATC code
- H01AA02
- ATC class
- Tetracosactide
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 4
- no_varenummer3307611
- no_merkevare_idID_96F9F21B-A168-4C30-9105-5E5530332A1E
- no_varenummer24269310 x 1
- gtin4150009972818
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
295 interactions on record for tetracosactide.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tetracosactide · interactions on record
295 records
- 29 severe
- 246 moderate
- 20 minor
Most severe, free to view
- DesirudinB01AE01severe
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Liquid paraffinA06AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tetracosactide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCortrosynHenry Schein, Inc.
- United KingdomSynacthen 250micrograms/1ml solution for injection ampoulesAtnahs Pharma UK Ltd
- CanadaCORTROSYN INJ 0.25MGAMPHASTAR PHARMACEUTICALS, INC.
- FranceSYNACTHENE 0,25 mg/1 ml, solution injectableALFASIGMA (ITALIE)
- SpainNUVACTHEN DEPOT 1MG/ML SUSPENSIÓN INYECTABLEAlfasigma S.P.A.
- Japanテトラコサクチド酢酸塩アルフレッサファーマ
- NetherlandsSynacthen 0,25 mg/ml, oplossing voor injectie of infusieAlfasigma S.p.A.
- SwedenSynacthen 0,25 mg/ml Injektions-/infusionsvätska, lösningAlfasigma S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Synacthen Ampulle, Synacthen Depot
- Belgium · Synacthen, Synacthen Depot
- Denmark · Synacthen
- France · Synacthene, Synacthene Retard
- Ireland · Synacthen
- Italy · Synacthen
- Luxembourg · Synacthen, Synacthen Dépôt
- Netherlands · Synacthen
- Sweden · Synacthen, Synacthen Depot
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e36f4db-cb6f-4cad-9ac4-6690171a1774 GET /v1/drugs/4e36f4db-cb6f-4cad-9ac4-6690171a1774?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Tetrakosaktid",
"merkevare_id": "ID_96F9F21B-A168-4C30-9105-5E5530332A1E",
"name_form_strength": "Synacthen inj, oppl 250 mikrog/ml",
"prescription_group": "C"
}See everything about tetracosactide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.